Phibro Animal Health (PAHC) EBT Margin Growth (1y) (2013 - 2026)
Phibro Animal Health (PAHC) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | -11.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00 |
| Dec 31, 2025 | 818.00 |
| Sep 30, 2025 | 627.00 |
| Jun 30, 2025 | 1,630.00 |
| Mar 31, 2025 | 363.00 |
| Dec 31, 2024 | 14.00 |
| Sep 30, 2024 | 887.00 |
| Jun 30, 2024 | -1,841.00 |
| Mar 31, 2024 | -124.00 |
| Dec 31, 2023 | -352.00 |
| Sep 30, 2023 | -751.00 |
| Jun 30, 2023 | 356.00 |
| Mar 31, 2023 | -505.00 |
| Dec 31, 2022 | -516.00 |
| Sep 30, 2022 | -214.00 |
| Jun 30, 2022 | -247.00 |
| Mar 31, 2022 | 280.00 |
| Dec 31, 2021 | 232.00 |
| Sep 30, 2021 | -399.00 |
| Jun 30, 2021 | 3,006.00 |